the Private Securities Litigation Reform
Act of 1995: This press release contains forward-looking statements as
defined in Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Such
forward-looking statements are based upon Unigene Laboratories, Inc.'s
management's current expectations, estimates, beliefs, assumptions, and
projections about Unigene's business and industry. Words such as
"anticipates," "expects," "intends," "plans," "predicts," "believes,"
"seeks," "estimates," "may," "will," "should," "would," "potential,"
"continue," and variations of these words (or negatives of these words) or
similar expressions, are intended to identify forward-looking statements.
In addition, any statements that refer to expectations, projections, or
other characterizations of future events or circumstances, including any
underlying assumptions, are forward-looking statements. These
forward-looking statements are not guarantees of future performance and are
subject to certain risks, uncertainties, and assumptions that are difficult
to predict. Therefore, our actual results could differ materially and
adversely from those expressed in any forward-looking statements as a
result of various risk factors. These risks and uncertainties include the
risks associated with the effect of changing economic conditions, trends in
the products markets, variations in Unigene's cash flow, market acceptance
risks, technical development risks and other risk factors detailed in
Unigene's Securities and Exchange Commission filings.
Warren P. Levy
President and CEO
Unigene Laboratories, Inc.
110 Little Falls Road
Fairfield, NJ 07004
Page: 1 2 Related biology technology :1
|SOURCE Unigene Laboratories Inc.|
Copyright©2008 PR Newswire.
All rights reserved
. Stonegate Report About Unigene Laboratories Inc.2
. U.S. Preventive Medicine National Policy Advisor Gov. Tommy Thompson to Propose Prevention is the Solution at UBS Global Health Services Conference3
. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum4
. Bioscience Group Warns Policymakers Against Complacency5
. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities6
. Sales of Stem Cell Products Expected to Reach $87 Million in 2008, Leading Medical Industry Analyst Says7
. Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing8
. Medco to Webcast Annual Analyst Day Conference9
. Webcast Alert: Isis Pharmaceuticals Announces its Analyst & Investor Day10
. DURECT to Host Webcast in Conjunction with an Analysts Day on October 1711
. Nu Skin Enterprises to Hold 2007 Analyst Day